36429082|t|Higher Circulating Trimethylamine N-Oxide Aggravates Cognitive Impairment Probably via Downregulating Hippocampal SIRT1 in Vascular Dementia Rats.
36429082|a|Oxidative stress and inflammation damage play pivotal roles in vascular dementia (VaD). Trimethylamine N-oxide (TMAO), an intestinal microbiota-stemming metabolite, was reported to promote inflammation and oxidative stress, involved in the etiology of several diseases. Still, these effects have not been investigated in VaD. Here, we tested whether pre-existing, circulating, high levels of TMAO could affect VaD-induced cognitive decline. TMAO (120 mg/kg) was given to rats for a total of 8 weeks, and these rats underwent a sham operation or bilateral common carotid artery (2VO) surgery after 4 weeks of treatment. Four weeks after surgery, the 2VO rats exhibited hippocampal-dependent cognitive function declines and synaptic plasticity dysfunction, accompanied by an increase in oxidative stress, neuroinflammation, and apoptosis. TMAO administration, which increased plasma and hippocampal TMAO at 4 weeks postoperatively, further aggravated these effects, resulting in exaggerated cognitive and synaptic plasticity impairment, though not within the Sham group. Moreover, TMAO treatment activated the NLRP3 inflammasome and decreased SIRT1 protein expression within the hippocampus. However, these effects of TMAO were significantly attenuated by the overexpression of SIRT1. Our findings suggest that TMAO increases oxidative stress-induced neuroinflammation and apoptosis by inhibiting the SIRT1 pathway, thereby exacerbating cognitive dysfunction and neuropathological changes in VaD rats.
36429082	19	41	Trimethylamine N-Oxide	Chemical	MESH:C005855
36429082	53	73	Cognitive Impairment	Disease	MESH:D003072
36429082	114	119	SIRT1	Gene	309757
36429082	123	140	Vascular Dementia	Disease	MESH:D015140
36429082	141	145	Rats	Species	10116
36429082	168	180	inflammation	Disease	MESH:D007249
36429082	210	227	vascular dementia	Disease	MESH:D015140
36429082	229	232	VaD	Disease	MESH:D015140
36429082	235	257	Trimethylamine N-oxide	Chemical	MESH:C005855
36429082	259	263	TMAO	Chemical	MESH:C005855
36429082	336	348	inflammation	Disease	MESH:D007249
36429082	468	472	VaD.	Disease	MESH:D015140
36429082	539	543	TMAO	Chemical	MESH:C005855
36429082	557	560	VaD	Disease	MESH:D015140
36429082	569	586	cognitive decline	Disease	MESH:D003072
36429082	588	592	TMAO	Chemical	MESH:C005855
36429082	618	622	rats	Species	10116
36429082	657	661	rats	Species	10116
36429082	702	716	common carotid	Disease	MESH:D002340
36429082	725	728	2VO	Disease	
36429082	796	799	2VO	Disease	
36429082	800	804	rats	Species	10116
36429082	837	864	cognitive function declines	Disease	MESH:D003072
36429082	869	900	synaptic plasticity dysfunction	Disease	MESH:D010411
36429082	950	967	neuroinflammation	Disease	MESH:D000090862
36429082	984	988	TMAO	Chemical	MESH:C005855
36429082	1044	1048	TMAO	Chemical	MESH:C005855
36429082	1136	1180	cognitive and synaptic plasticity impairment	Disease	MESH:D003072
36429082	1226	1230	TMAO	Chemical	MESH:C005855
36429082	1255	1260	NLRP3	Gene	287362
36429082	1288	1293	SIRT1	Gene	309757
36429082	1363	1367	TMAO	Chemical	MESH:C005855
36429082	1423	1428	SIRT1	Gene	309757
36429082	1456	1460	TMAO	Chemical	MESH:C005855
36429082	1496	1513	neuroinflammation	Disease	MESH:D000090862
36429082	1546	1551	SIRT1	Gene	309757
36429082	1582	1603	cognitive dysfunction	Disease	MESH:D003072
36429082	1608	1625	neuropathological	Disease	MESH:D009422
36429082	1637	1640	VaD	Disease	MESH:D015140
36429082	1641	1645	rats	Species	10116
36429082	Positive_Correlation	MESH:C005855	MESH:D000090862
36429082	Negative_Correlation	MESH:C005855	309757
36429082	Association	MESH:D000090862	309757
36429082	Positive_Correlation	MESH:C005855	MESH:D015140
36429082	Positive_Correlation	MESH:C005855	287362
36429082	Positive_Correlation	MESH:C005855	MESH:D003072
36429082	Positive_Correlation	MESH:C005855	MESH:D010411
36429082	Positive_Correlation	MESH:C005855	MESH:D007249

